Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model

The bidirectional pulsatile movement of cerebrospinal fluid (CSF), instead of the traditionally believed unidirectional and constant CSF circulation, has been demonstrated. In the present study, the structure and parameters of the CSF compartments were revisited in our comprehensive and validated ce...

Full description

Bibliographic Details
Main Authors: Makoto Hirasawa, Elizabeth C. M. de Lange
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/14/9/1764
_version_ 1797483668831207424
author Makoto Hirasawa
Elizabeth C. M. de Lange
author_facet Makoto Hirasawa
Elizabeth C. M. de Lange
author_sort Makoto Hirasawa
collection DOAJ
description The bidirectional pulsatile movement of cerebrospinal fluid (CSF), instead of the traditionally believed unidirectional and constant CSF circulation, has been demonstrated. In the present study, the structure and parameters of the CSF compartments were revisited in our comprehensive and validated central nervous system (CNS)-specific, physiologically based pharmacokinetic (PBPK) model of healthy rats (LeiCNS-PK3.0). The bidirectional and site-dependent CSF movement was incorporated into LeiCNS-PK3.0 to create the new LeiCNS-PK“3.1” model. The physiological CSF movement rates in healthy rats that are unavailable from the literature were estimated by fitting the PK data of sucrose, a CSF flow marker, after intra-CSF administration. The capability of LeiCNS-PK3.1 to describe the PK profiles of other molecules was compared with that of the original LeiCNS-PK3.0 model. LeiCNS-PK3.1 demonstrated superior description of the CSF PK profiles of a range of small molecules after intra-CSF administration over LeiCNS-PK3.0. LeiCNS-PK3.1 also retained the same level of predictability of CSF PK profiles in cisterna magna after intravenous administration. These results support the theory of bidirectional and site-dependent CSF movement across the entire CSF space over unidirectional and constant CSF circulation in healthy rats, pointing out the need to revisit the structures and parameters of CSF compartments in CNS-PBPK models.
first_indexed 2024-03-09T22:51:18Z
format Article
id doaj.art-6322cb82e42441bb9ce9a278b8f1cf65
institution Directory Open Access Journal
issn 1999-4923
language English
last_indexed 2024-03-09T22:51:18Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj.art-6322cb82e42441bb9ce9a278b8f1cf652023-11-23T18:20:03ZengMDPI AGPharmaceutics1999-49232022-08-01149176410.3390/pharmaceutics14091764Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic ModelMakoto Hirasawa0Elizabeth C. M. de Lange1Division of Systems Pharmacology and Pharmacy, Leiden Academic Center for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsDivision of Systems Pharmacology and Pharmacy, Leiden Academic Center for Drug Research, Leiden University, 2333 CC Leiden, The NetherlandsThe bidirectional pulsatile movement of cerebrospinal fluid (CSF), instead of the traditionally believed unidirectional and constant CSF circulation, has been demonstrated. In the present study, the structure and parameters of the CSF compartments were revisited in our comprehensive and validated central nervous system (CNS)-specific, physiologically based pharmacokinetic (PBPK) model of healthy rats (LeiCNS-PK3.0). The bidirectional and site-dependent CSF movement was incorporated into LeiCNS-PK3.0 to create the new LeiCNS-PK“3.1” model. The physiological CSF movement rates in healthy rats that are unavailable from the literature were estimated by fitting the PK data of sucrose, a CSF flow marker, after intra-CSF administration. The capability of LeiCNS-PK3.1 to describe the PK profiles of other molecules was compared with that of the original LeiCNS-PK3.0 model. LeiCNS-PK3.1 demonstrated superior description of the CSF PK profiles of a range of small molecules after intra-CSF administration over LeiCNS-PK3.0. LeiCNS-PK3.1 also retained the same level of predictability of CSF PK profiles in cisterna magna after intravenous administration. These results support the theory of bidirectional and site-dependent CSF movement across the entire CSF space over unidirectional and constant CSF circulation in healthy rats, pointing out the need to revisit the structures and parameters of CSF compartments in CNS-PBPK models.https://www.mdpi.com/1999-4923/14/9/1764cerebrospinal fluidCSFCSF physiologybidirectional pulsatile CSF movementintra-CSF administrationphysiologically based pharmacokinetic model
spellingShingle Makoto Hirasawa
Elizabeth C. M. de Lange
Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model
Pharmaceutics
cerebrospinal fluid
CSF
CSF physiology
bidirectional pulsatile CSF movement
intra-CSF administration
physiologically based pharmacokinetic model
title Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model
title_full Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model
title_fullStr Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model
title_full_unstemmed Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model
title_short Revisiting Cerebrospinal Fluid Flow Direction and Rate in Physiologically Based Pharmacokinetic Model
title_sort revisiting cerebrospinal fluid flow direction and rate in physiologically based pharmacokinetic model
topic cerebrospinal fluid
CSF
CSF physiology
bidirectional pulsatile CSF movement
intra-CSF administration
physiologically based pharmacokinetic model
url https://www.mdpi.com/1999-4923/14/9/1764
work_keys_str_mv AT makotohirasawa revisitingcerebrospinalfluidflowdirectionandrateinphysiologicallybasedpharmacokineticmodel
AT elizabethcmdelange revisitingcerebrospinalfluidflowdirectionandrateinphysiologicallybasedpharmacokineticmodel